All News

Improving End-of-Life Care: Making Hospice and Home Support Accessible

October 22nd 2025, 1:00pm

Video

Experts discuss how better hospice and home care reimbursement can help patients receive compassionate end-of-life care at home.

Stage 1 Multiple Myeloma Treatment Options and Side Effect Management

October 21st 2025, 9:00pm

Article

Get the facts on stage 1 multiple myeloma, including why your doctor may recommend active surveillance and what the latest treatment options are.

Verzenio Plus Endocrine Therapy Benefits Survival for Some With Breast Cancer

October 21st 2025, 8:00pm

Article

The addition of postsurgical Verzenio to endocrine therapy provided a benefit in HR–positive, HER2-negative breast cancer.

Understanding Your Stage 2 Ovarian Cancer

October 21st 2025, 7:00pm

Article

Learn what stage 2 ovarian cancer means, how it’s diagnosed, treatment options like surgery and chemotherapy, and key questions to ask your oncologist.

A Breast Cancer Survivor's Delightful Dilemma

October 21st 2025, 5:00pm

Article

Shopping for prostheses reminded me of being in a very popular old toy store.

Stem Cell Transplant: Why This Treatment Is Still a ‘Standard Regimen’ for Blood Cancer

October 21st 2025, 3:56pm

Article

Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T cell therapy is changing treatment decisions.

Buparlisib Plus Chemo Fails to Improve Head and Neck Cancer Survival

October 21st 2025, 3:27pm

Article

In PD-1/PD-L1-pretreated recurrent/metastatic head and neck squamous cell carcinoma buparlisib and paclitaxel was not associated with a survival improvement.

GammaTile May Reduce Risk of Brain Tumor Recurrence or Death

October 21st 2025, 3:00pm

Article

In patients with operable, newly diagnosed brain metastases, GammaTile was associated with reduction in the risk of tumor recurrence or death.

Breast Cancer Survivors Share Advice for Newly Diagnosed Patients

October 21st 2025, 1:00pm

Video

Breast cancer survivors highlighted guidance and encouragement they received when first diagnosed, offering reassurance for those who are newly diagnosed.

VCN-01 with Standard Care Boosts Survival, Shows Safety in PDAC

October 20th 2025, 10:00pm

Article

VCN-01 plus standard chemotherapy and Abraxane proved safe and effective for patients with metastatic pancreatic cancer.